AAMU
UTHR icon

APG Asset Management US’s United Therapeutics UTHR Stock Holding History

APG Asset Management US’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-873
Closed -$383K – 174
2025
Q3 		$383K Hold
873
– – ﹤0.01% 172
2025
Q2 		$254K Hold
873
– – ﹤0.01% 184
2025
Q1 		$268K Hold
873
– – ﹤0.01% 190
2024
Q4 		$308K Sell
873
-165
-16% -$60.6K ﹤0.01% 186
2024
Q3 		$371K Sell
1,038
-12,130
-92% -$4.1M ﹤0.01% 149
2024
Q2 		$4.2M Buy
13,168
+282
+2% +$74.6K 0.02% 150
2024
Q1 		$2.94M Buy
12,886
+4,074
+46% +$919K 0.02% 167
2023
Q4 		$1.94M Buy
+8,812
New +$2.03M 0.01% 176

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

APG Asset Management US's UTHR Position: Q4 2025 in Review

APG Asset Management US sold out of United Therapeutics (UTHR) in Q4 2025, closing a stake of 873 shares — an estimated $383K sold.

APG Asset Management US first reported a position in UTHR in Q4 2023 and held it in 8 quarters. The position peaked at $4.2M in Q2 2024. 838 funds tracked by Wall St. Rank hold UTHR as of Q4 2025.

  • APG Asset Management US reported no remaining United Therapeutics position as of Q4 2025 after selling out during the quarter.
  • APG Asset Management US sold 873 United Therapeutics shares in Q4 2025, an estimated $383K.
  • APG Asset Management US first reported a position in United Therapeutics in Q4 2023 and held it in 8 quarters.
  • APG Asset Management US's United Therapeutics position peaked at $4.2M in Q2 2024.
  • 838 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.